CN Stock MarketDetailed Quotes

002589 Realcan Pharmaceutical Group

Watchlist
  • 2.58
  • -0.01-0.39%
Noon Break May 29 11:30 CST
3.88BMarket Cap258.00P/E (TTM)

Realcan Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Realcan Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

2.02B

-2.62%
EPS(YoY)

0.01

-28.57%
Analyst Rating

No Data

Realcan Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 30, 20192019/Q18.742B / 7.504B--
DatePeriodRevenue/EstimateEarnings Call
Apr 30, 20192019/Q18.742B / 7.504B--

Realcan Pharmaceutical Group Earnings Reports

  • Realcan Pharmaceutical Group: 2024 First Quarter Report

    Apr 29 12:00 ET

  • Realcan Pharmaceutical Group: 2023 ANNUAL REPORT

    Apr 29 12:00 ET

  • Realcan Pharmaceutical Group: 2023 Annual Report Summary

    Apr 29 12:00 ET

  • Ruikang Pharmaceutical: 2023 performance forecast

    Jan 30 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg